BSX:FRA
Boston Scientific Corp
€37.50
arrow_downward
-0.85%(-0.32) 1D
Sep 21, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSX...
Open
€37.76
High
€37.76
Low
€37.50
Mkt. cap
63.36B
Avg. vol.
587.00
Volume
146.00
52-wk high
€91.20
52-wk low
€36.59
No. of employees
59K
Open
€37.76
High
€37.76
Low
€37.50
Mkt. cap
63.36B
Avg. vol.
587.00
Volume
146.00
52-wk high
€91.20
52-wk low
€36.59
No. of employees
59K
News stories
From web sources and news partners
AD HOC NEWS
·
1 hour ago
Boston Scientific stock heads into the open after a 0.9% gain
Simply Wall Street
·
2 days ago
Boston Scientific (BSX) Stock Could Be A Bargain On Strong Cash Flow Views
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator.
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp
CEOMichael F. Mahoney
Employees59K
FoundedJun 29, 1979
HeadquartersMarlborough, Massachusetts, United States
SectorMedical device
Websitebostonscientific.com